title: Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
authors.affiliation: Dipartimento di Medicina Cardiovascolare, Policlinico A. Gemelli, Catholic University, Largo Gemelli 8, Rome, Italy. sdepaul@tin.it
authors.forename: Stefano
authors.initials: S
authors.lastname: De Paulis
authors.forename: Elena
authors.initials: E
authors.lastname: Rossi
authors.forename: Roberto
authors.initials: R
authors.lastname: Zamparelli
authors.forename: Andrea
authors.initials: A
authors.lastname: Scapigliati
authors.forename: Michele
authors.initials: M
authors.lastname: Corrado
authors.forename: Valerio
authors.initials: V
authors.lastname: De Stefano
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D020878:Device Removal; D005165:Factor V / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation; D006579:Heterozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D009154:Mutation; D011516:Prothrombin / Q000235:genetics*; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications* / Q000235:genetics; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics / Q000601:surgery; D013997:Time Factors; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; C095381:factor V Leiden; D014859:Warfarin; D005165:Factor V; D011516:Prothrombin